-DOCSTART- -X- O
Hand -X- _ O
, -X- _ O
foot -X- _ O
and -X- _ O
mouth -X- _ O
disease -X- _ O
caused -X- _ O
by -X- _ O
enterovirus -X- _ B-Patient
71 -X- _ I-Patient
( -X- _ I-Patient
EV71 -X- _ I-Patient
) -X- _ I-Patient
leads -X- _ O
to -X- _ O
the -X- _ O
majority -X- _ O
of -X- _ O
neurological -X- _ O
complications -X- _ O
and -X- _ O
death -X- _ O
in -X- _ O
young -X- _ O
children. -X- _ O
While -X- _ O
putative -X- _ O
inactivated -X- _ O
vaccines -X- _ O
are -X- _ O
only -X- _ O
now -X- _ O
undergoing -X- _ O
clinical -X- _ O
trials -X- _ O
, -X- _ O
no -X- _ O
specific -X- _ O
treatment -X- _ O
options -X- _ O
exist -X- _ O
yet. -X- _ O
Ideally -X- _ O
, -X- _ O
EV71 -X- _ O
specific -X- _ O
intravenous -X- _ O
immunoglobulins -X- _ O
could -X- _ O
be -X- _ O
developed -X- _ O
for -X- _ O
targeted -X- _ O
treatment -X- _ O
of -X- _ O
severe -X- _ O
cases. -X- _ O
To -X- _ O
date -X- _ O
, -X- _ O
only -X- _ O
a -X- _ O
single -X- _ O
universally -X- _ O
neutralizing -X- _ O
monoclonal -X- _ O
antibody -X- _ O
against -X- _ O
a -X- _ O
conserved -X- _ O
linear -X- _ O
epitope -X- _ O
of -X- _ O
VP1 -X- _ O
has -X- _ O
been -X- _ O
identified. -X- _ O
Other -X- _ O
enteroviruses -X- _ O
have -X- _ O
been -X- _ O
shown -X- _ O
to -X- _ O
possess -X- _ O
major -X- _ O
conformational -X- _ O
neutralizing -X- _ O
epitopes -X- _ O
on -X- _ O
both -X- _ O
the -X- _ O
VP2 -X- _ O
and -X- _ O
VP3 -X- _ O
capsid -X- _ O
proteins. -X- _ O
Hence -X- _ O
, -X- _ O
we -X- _ O
attempted -X- _ O
to -X- _ O
isolate -X- _ O
such -X- _ O
neutralizing -X- _ O
antibodies -X- _ O
against -X- _ O
conformational -X- _ O
epitopes -X- _ O
for -X- _ O
their -X- _ O
potential -X- _ O
in -X- _ O
the -X- _ O
treatment -X- _ O
of -X- _ O
infection -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
differential -X- _ O
diagnosis -X- _ O
and -X- _ O
vaccine -X- _ O
optimization. -X- _ O
Here -X- _ O
we -X- _ O
describe -X- _ O
a -X- _ O
universal -X- _ B-Intervention
neutralizing -X- _ I-Intervention
monoclonal -X- _ I-Intervention
antibody -X- _ I-Intervention
that -X- _ O
recognizes -X- _ O
a -X- _ O
conserved -X- _ O
conformational -X- _ O
epitope -X- _ O
of -X- _ O
EV71 -X- _ O
which -X- _ O
was -X- _ O
mapped -X- _ O
using -X- _ O
escape -X- _ O
mutants. -X- _ O
Eight -X- _ B-Outcome
escape -X- _ I-Outcome
mutants -X- _ I-Outcome
from -X- _ I-Outcome
different -X- _ I-Outcome
subgenogroups -X- _ I-Outcome
( -X- _ I-Outcome
A -X- _ I-Outcome
, -X- _ I-Outcome
B2 -X- _ I-Outcome
, -X- _ I-Outcome
B4 -X- _ I-Outcome
, -X- _ I-Outcome
C2 -X- _ I-Outcome
, -X- _ I-Outcome
C4 -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
rescued -X- _ I-Outcome
; -X- _ I-Outcome
they -X- _ I-Outcome
harbored -X- _ I-Outcome
three -X- _ I-Outcome
essential -X- _ I-Outcome
mutations -X- _ I-Outcome
either -X- _ I-Outcome
at -X- _ I-Outcome
amino -X- _ I-Outcome
acid -X- _ I-Outcome
positions -X- _ I-Outcome
59 -X- _ I-Outcome
, -X- _ I-Outcome
62 -X- _ I-Outcome
or -X- _ I-Outcome
67 -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
VP3 -X- _ I-Outcome
protein -X- _ I-Outcome
which -X- _ I-Outcome
are -X- _ I-Outcome
all -X- _ I-Outcome
situated -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
“knob” -X- _ I-Outcome
region. -X- _ I-Outcome
The -X- _ I-Outcome
escape -X- _ I-Outcome
mutant -X- _ I-Outcome
phenotype -X- _ I-Outcome
could -X- _ I-Outcome
be -X- _ I-Outcome
mimicked -X- _ I-Outcome
by -X- _ I-Outcome
incorporating -X- _ I-Outcome
these -X- _ I-Outcome
mutations -X- _ I-Outcome
into -X- _ I-Outcome
reverse -X- _ I-Outcome
genetically -X- _ I-Outcome
engineered -X- _ I-Outcome
viruses -X- _ I-Outcome
showing -X- _ I-Outcome
that -X- _ I-Outcome
P59L -X- _ I-Outcome
, -X- _ I-Outcome
A62D -X- _ I-Outcome
, -X- _ I-Outcome
A62P -X- _ I-Outcome
and -X- _ I-Outcome
E67D -X- _ I-Outcome
abolish -X- _ I-Outcome
both -X- _ I-Outcome
monoclonal -X- _ I-Outcome
antibody -X- _ I-Outcome
binding -X- _ I-Outcome
and -X- _ I-Outcome
neutralization -X- _ I-Outcome
activity. -X- _ I-Outcome
This -X- _ O
is -X- _ O
the -X- _ O
first -X- _ O
conformational -X- _ O
neutralization -X- _ O
epitope -X- _ O
mapped -X- _ O
on -X- _ O
VP3 -X- _ O
for -X- _ O
EV71 -X- _ O
. -X- _ O

